{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:13:51Z","timestamp":1790993631597,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.ijpharm.2013.03.033","type":"journal-article","created":{"date-parts":[[2013,3,25]],"date-time":"2013-03-25T15:19:44Z","timestamp":1364224784000},"page":"159-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin"],"prefix":"10.1016","volume":"448","author":[{"given":"Xiaoli","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2013.03.033_bib0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Anderson","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bbrc.2009.11.073","article-title":"Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study","volume":"391","author":"Aroui","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0015","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.bbamem.2010.09.001","article-title":"Happy birthday cell penetrating peptides: already 20 years","volume":"1798","author":"Brasseur","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0020","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1016\/j.biomaterials.2011.08.087","article-title":"A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery","volume":"32","author":"Chen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/iub.297","article-title":"Cell-Penetrating peptides: nanocarrier for macromolecule delivery in living cells","volume":"62","author":"Chugh","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0030","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.addr.2009.06.001","article-title":"Recent advances in the use of cell-penetrating peptides for medical and biological applications","volume":"61","author":"Fonseca","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0035","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.addr.2007.09.003","article-title":"Predicting cell-penetrating peptides","volume":"60","author":"Hansen","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2008.07.016","article-title":"Permeation characteristics of oligoarginine through intestinal epithelium and its usefulness for intestinal peptide drug delivery","volume":"131","author":"Kamei","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2008.08.001","article-title":"Usefulness of cell-penetrating peptides to improve intestinal insulin absorption","volume":"132","author":"Kamei","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2009.02.015","article-title":"Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide\/protein absorption using cell-penetrating peptides","volume":"136","author":"Kamei","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jconrel.2008.09.076","article-title":"Effect of cell-penetrating peptides on the nasal absorption of insulin","volume":"133","author":"Khafagy","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2009.07.022","article-title":"Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins","volume":"381","author":"Khafagy","year":"2009","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0065","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1039\/c004684a","article-title":"Lipo-oligoarginines as effective delivery vectors to promote cellular uptake","volume":"6","author":"Lee","year":"2010","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0070","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbrc.2005.07.142","article-title":"Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency","volume":"335","author":"Liang","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jconrel.2005.05.001","article-title":"Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugs","volume":"106","author":"Lim","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1042\/bj20030760","article-title":"Passage of cell-penetrating peptides across a human epithelial cell layer in vitro","volume":"377","author":"Lindgren","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0085","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jconrel.2005.03.027","article-title":"Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery","volume":"107","author":"Lu","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0090","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijpharm.2009.10.014","article-title":"LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors","volume":"385","author":"Lu","year":"2010","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0095","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1034\/j.1399-3011.2000.00723.x","article-title":"Polyarginine enters cells more efficiently than other polycationic homopolymers","volume":"56","author":"Mitchell","year":"2000","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0100","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.drudis.2006.08.005","article-title":"Is the oral route possible for peptide and protein drug delivery?","volume":"11","author":"Morishita","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2006.12.022","article-title":"A novel approach using functional peptides for efficient intestinal absorption of insulin","volume":"118","author":"Morishita","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.reactfunctpolym.2010.10.002","article-title":"Oral protein delivery. Current status and future prospect","volume":"71","author":"Park","year":"2011","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0120","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cocis.2010.12.005","article-title":"Fate of polymeric nanocarriers for oral drug delivery","volume":"16","author":"Plapied","year":"2011","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10611860410001693760","article-title":"Use of targeting agents to increase uptake and localization of drugs to the intestinal epithelium","volume":"12","author":"Russell-Jones","year":"2004","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0130","doi-asserted-by":"crossref","first-page":"494a","DOI":"10.1016\/j.bpj.2010.12.2898","article-title":"Cell penetrating peptides. How do they cross membranes?","volume":"100","author":"Seelig","year":"2011","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/1061186X.2010.483517","article-title":"Poly(ethylene glycol)-block-poly(d,l-lactide acid) micelles anchored with angiopep-2 for brain-targeting delivery","volume":"19","author":"Shen","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0140","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s11095-010-0345-x","article-title":"Uptake and transport of novel amphiphilic polyelectrolyte-insulin nanocomplexes by Caco-2 cells\u2014towards oral insulin","volume":"28","author":"Thompson","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0145","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3390\/ph3040961","article-title":"Cell-penetrating peptides\u2014mechanisms of cellular uptake and generation of delivery systems","volume":"3","author":"Trabulo","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejpb.2004.02.018","article-title":"Chances and pitfalls of cell penetrating peptides for cellular drug delivery","volume":"58","author":"Trehin","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2005.09.032","article-title":"Present and future of cell-penetrating peptide mediated delivery systems: is the Trojan horse too wild to go only to Troy?","volume":"109","author":"Vives","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0160","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bbamem.2010.09.009","article-title":"Different membrane behaviour and cellular uptake of three basic arginine-rich peptides","volume":"1808","author":"Walrant","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0165","doi-asserted-by":"crossref","first-page":"16275","DOI":"10.1074\/jbc.M110.102749","article-title":"Trp-26 imparts functional versatility to human \u03b1-defensin HNP1","volume":"285","author":"Wei","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bmcl.2009.11.026","article-title":"Investigation of the sequence and length dependence for cell-penetrating prenylated peptides","volume":"20","author":"Wollack","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0175","doi-asserted-by":"crossref","first-page":"9888","DOI":"10.1016\/j.biomaterials.2011.09.004","article-title":"Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration","volume":"32","author":"Xia","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0180","article-title":"Cell-penetrating peptide-modified PLGA nanoparticles for enhanced nose-to-brain macromolecular delivery","author":"Yan","year":"2012","journal-title":"Macromol. Res."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0185","first-page":"574","article-title":"Novel solid lipid nanoparticles as carriers for oral administration of insulin","volume":"64","author":"Zhang","year":"2009","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0190","first-page":"3333","article-title":"Solid lipid nanoparticles modified with stearic acid-octaarginine for oral administration of insulin","volume":"7","author":"Zhang","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2013.03.033_bib0195","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.addr.2004.10.010","article-title":"Cell-penetrating peptides: mechanism and kinetics of cargo delivery","volume":"57","author":"Zorko","year":"2005","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517313002524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517313002524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T19:22:46Z","timestamp":1539804166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517313002524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0378517313002524"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2013.03.033","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2013.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}